Wedbush Adjusts Price Target on Astria Therapeutics to $26 From $27, Keeps Outperform Rating
Wedbush Adjusts Price Target on Astria Therapeutics to $26 From $27, Keeps Outperform Rating
Wedbush 調整阿斯特里亞治療的目標價格從 27 美元至 26 美元，保持「跑贏大市」評級
Unity Software(U.US) reported fourth-quarter financial results after the market close on Monday. Here's a rundown of the report.Q4 Earnings: Unity said fourth-quarter revenue increased 35% year-over-year to $609 million, beating the consensus estimate of $562.71 million. The company reported a quarterly loss of 66 cents per share.
登入免費觀看全文
登入/註冊